Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir.
about
Overview of hepatitis B virus mutations and their implications in the management of infectionSelection and counterselection of the rtI233V adefovir resistance mutation during antiviral therapy.Clinical implications of hepatitis B virus mutations: recent advances.Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.Resistant mutants induced by adefovir dipivoxil in hepatitis B virus isolates.HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya.Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients.Antiviral resistance and hepatitis B therapy.The impact of the hepatitis B virus polymerase rtA181T mutation on replication and drug resistance is potentially affected by overlapping changes in surface gene.Impact of rtI233V mutation in hepatitis B virus polymerase protein and adefovir efficacy: Homology modeling and molecular docking studies.Clonal analysis of hepatitis B viruses among blood donors from Joinville, Brazil: evidence of dual infections, intragenotype recombination and markers of risk for hepatocellular carcinoma.Antiviral resistance mutations and genotype-associated amino acid substitutions in treatment-naïve hepatitis B virus-infected individuals from the Indian subcontinent.Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites.
P2860
Q26772346-98A881C4-9978-4C9B-8C1E-6DCC4A598208Q33627462-2A917455-97CA-4695-BC9D-C978F2C0FD0AQ33801311-F84E2460-41A8-4488-A77E-574C49386C5AQ34489239-DBE412FA-74D7-4FC6-87F5-D8F149A9261FQ34647599-1C0DCA28-E86C-47A7-A5BD-23845ADC8423Q35224111-4844EE50-61D0-45E1-96C6-0EBD4C4F7EC2Q36765571-FB5069E6-A617-4E63-A624-FA544CF0A3B1Q37255008-90B3027B-E4C7-4815-B3E4-EE5A0761DA04Q40605404-D2C75B63-31B0-43E6-84DC-2111160AAABEQ43239984-7EA6FF18-C146-441C-B755-7D5B67A19203Q44284503-A07F6BD4-C152-4D68-85C2-7AB4B2139CE9Q44462426-0FB09161-E1EA-4704-B62C-FC543EA6048CQ45363333-0478979C-3A9D-4E93-8CEE-5B44A5A0FE89
P2860
Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Hepatitis B virus containing t ...... ive to inhibition by adefovir.
@en
Hepatitis B virus containing t ...... ive to inhibition by adefovir.
@nl
type
label
Hepatitis B virus containing t ...... ive to inhibition by adefovir.
@en
Hepatitis B virus containing t ...... ive to inhibition by adefovir.
@nl
prefLabel
Hepatitis B virus containing t ...... ive to inhibition by adefovir.
@en
Hepatitis B virus containing t ...... ive to inhibition by adefovir.
@nl
P2093
P356
P1476
Hepatitis B virus containing t ...... ive to inhibition by adefovir.
@en
P2093
Katyna Borroto-Esoda
Maria Curtis
P304
P356
10.1086/522521
P407
P577
2007-10-31T00:00:00Z